Skip to main content
TipRanks
Go Ultimate75% OFF

Scott Dunseth Myers Insider Profile

11 Followers

Scott Dunseth Myers, Director at Zentalis Pharmaceuticals, holds 395.89K shares in Zentalis Pharmaceuticals (Ticker: ZNTL), holds ― shares in Amag Pharmaceuticals (Ticker: AMAG), holds 0.00 shares in Dynavax (Ticker: DVAX).

Scott Dunseth Myers's Trading History

ZNTL
Zentalis Pharmaceuticals
Jun 18, 2026DirectorUninformative Buy―$538.42K
DVAX
Dynavax
Feb 10, 2026―Uninformative Sell―$0.00
HARP
Harpoon Therapeutics
Mar 11, 2024―Uninformative Sell―$0.00
VRDN
Viridian Therapeutics
Apr 12, 2023CEO, DirectorInformative Buy101.44K$7.82M
RNAC
Cartesian Therapeutics
Dec 26, 2019DirectorUninformative Buy57.54K$509.32K
CASC
Cascadian Therapeutics
Mar 13, 2018―Uninformative Sell―$0.00
~TRIL
Trillium Therapeutics
――――
AMAG
Amag Pharmaceuticals
――――

You May Also Like

Scott Dunseth Myers insider profile FAQ

What is the percentage of profitable transactions made by Scott Dunseth Myers?
The percentage of profitable transactions made by Scott Dunseth Myers is 50%.
What is the average return per transaction made by Scott Dunseth Myers?
The average return per transaction made by Scott Dunseth Myers is 64.20%.
What stocks does Scott Dunseth Myers hold?
Scott Dunseth Myers holds: ZNTL, AMAG, DVAX, CASC, VRDN, ~TRIL, RNAC, HARP stocks.
What was Scott Dunseth Myers's most profitable transaction?
Scott Dunseth Myers’s most profitable transaction was an Informative Buy of ZNTL stock on April 30, 2025. The return on the trade was 182.30%.
What is Scott Dunseth Myers's role in Zentalis Pharmaceuticals?
Scott Dunseth Myers's role in Zentalis Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.